Antibodies to SARS-CoV-2 in patients with primary immunodeficiencies treated with nonspecific immunoglobulins

Jorge Eguía^{1

2}, M Araceli Caballero-Rabasco^{2

3}, M Lourdes Cos^{2

4}, Santiago Grau⁵, Leonardo Mellibovsky^{2

4}, Eduardo Villegas^{1

2}, Fabiola Blasco^{4

6

7}, Ana Lemus^{4

6}, Marta Crespo⁸, Eduardo Padilla¹, Ramón Gimeno^{2

7

9

10}

Affiliations

¹ Laboratori de Referència de Catalunya SA, El Prat de Llobregat, Spain.
² Immunodeficiencies Unit, Hospital del Mar, Barcelona, Spain.
³ Department of Pediatrics, Hospital del Mar, Barcelona, Spain.
⁴ Department of Internal Medicine, Hospital del Mar, Barcelona, Spain.
⁵ Department of Pharmacy, Hospital del Mar, Barcelona, Spain.
⁶ Department of Infectious Diseases, Hospital del Mar, Barcelona, Spain.
⁷ Laboratory of Immunology, Department of Pathology, Hospital del Mar, Barcelona.
⁸ Department of Nephrology, Hospital del Mar, Barcelona, Spain.
⁹ Immunity and Infection, Hospital del Mar Medical Research Institute, Barcelona, Spain.
¹⁰ Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain.

Jorge Eguía et al. Immunology. 2022 Aug.

. 2022 Aug;166(4):539-542.

doi: 10.1111/imm.13495. Epub 2022 May 31.

¹ Laboratori de Referència de Catalunya SA, El Prat de Llobregat, Spain.
² Immunodeficiencies Unit, Hospital del Mar, Barcelona, Spain.
³ Department of Pediatrics, Hospital del Mar, Barcelona, Spain.
⁴ Department of Internal Medicine, Hospital del Mar, Barcelona, Spain.
⁵ Department of Pharmacy, Hospital del Mar, Barcelona, Spain.
⁶ Department of Infectious Diseases, Hospital del Mar, Barcelona, Spain.
⁷ Laboratory of Immunology, Department of Pathology, Hospital del Mar, Barcelona.
⁸ Department of Nephrology, Hospital del Mar, Barcelona, Spain.
⁹ Immunity and Infection, Hospital del Mar Medical Research Institute, Barcelona, Spain.
¹⁰ Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain.

No abstract available

Conflict of interest statement

The authors have no conflicts of interest to declare.

1. Johns Hopkins University & Medicine . Coronavirus Resource Center. Available at: https://coronavirus.jhu.edu/map.html Accessed November 2021
1. Shields AM, Burns SO, Savic S, Richter AG, UK PIN COVID‐19 Consortium . COVID‐19 in patients with primary and secondary immunodeficiency: the United Kingdom experience. J Allergy Clin Immunol. 2021;147(3):870–5. - PMC - PubMed
1. Bucciol G, Tangye SG, Meyts I. Coronavirus disease 2019 in patients with inborn errors of immunity: lessons learned. Curr Opin Pediatr. 2021;33(6):648–56. - PMC - PubMed
1. Crespo M, Barrilado‐Jackson A, Padilla E, Eguía J, Echeverria‐Esnal D, Cao H, et al. Negative immune responses to two‐dose mRNA COVID‐19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring. Am J Transplant. 2021;22:786–800. 10.1111/ajt.16854 - DOI - PMC - PubMed
1. Wu J, Liang B, Chen C, Wang H, Fang Y, Shen S, et al. SARS‐CoV‐2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID‐19. Nat Commun. 2021;12(1):1813–22. - PMC - PubMed